Active surveillance is an alternative management for patients with a low clinical stage based on digital rectal examination (DRE) of the prostate, favorable prostate-specific antigen (PSA) levels evolution, low biopsy tumor grade, and minor tumor volume. This evidence concerns the gene KLK3 and neoplasm.